Year: 2025
Type: article
Abstract: Common mental disorders (CMDs), such as depressive and anxiety disorders, constitute a significant public health problem in low- and middle-income countries, such as India, where they rank among the leading causes of disability and impaired quality of life. Outcomes are further compromised by a large treatment gap, poor adherence to therapeutic regimens, and high attrition rates. The prevalence and severity of CMDs are disproportionately higher in women. Additionally, structural factors influencing healthcare access, along with sociocultural factors, such as gender-based violence, limited autonomy in healthcare decisions, and greater levels of discrimination and stigma, result in poorer outcomes among women with CMDs. Therefore, there is a pressing need for care packages that are culturally sensitive, gender-responsive, and designed to address these structural and sociocultural factors, as highlighted in the literature from India.
Source: World Journal of Psychiatry
Language: English
Subfield: Social Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: diamond
Funders: Bill and Melinda Gates Foundation, GAVI Alliance, Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Teva Pharmaceutical Industries, Alexion Pharmaceuticals, Edwards Lifesciences, International Parkinson and Movement Disorder Society, Boston Scientific Corporation, Wellcome Trust, Amicus Therapeutics, Fresenius Medical Care North America, Agios Pharmaceuticals, National Institute of Mental Health and Neurosciences, Department of Health and Social Care, National Research Foundation, Department of Biotechnology, Ministry of Science and Technology, India, Department of Science and Technology, Ministry of Science and Technology, India, Indian Council of Medical Research, Ministry of Education, Culture, Sports, Science and Technology, King Saud University, Conselho Nacional de Desenvolvimento Científico e Tecnológico, National Research Foundation of Korea, Novo Nordisk, Astellas Pharma, The Wellcome Trust DBT India Alliance, Servier, Casen Recordati, H. Lundbeck A/S, Ministry of Science and ICT, South Korea, Idorsia Pharmaceuticals, National Institutes of Health, Allergan, Medical Research Council, National Health and Medical Research Council, Science and Engineering Research Board, Fundação para a Ciência e a Tecnologia, Japan Science and Technology Agency, Biotechnology Industry Research Assistance Council, Norwegian Institute of Public Health, National Institute on Aging, National Institute of Mental Health, Precursory Research for Embryonic Science and Technology
Awards: G1483381719, G1690109813, G1694673581, Safeguarding the next generation: Using data to map and address injury-related harm in adolescence, G2164649689, G2243796125, G253812421, G3089902885, G3339216277, G3354586712, G3370693614, G3772864977, G3863394992, G4046065984, Associations of Opioid Prescribing with Long-term Functional Outcomes and Mortality Rates in Older Nursing Home Residents, G4531307644, G5454278309, G565055688, G6133462384, 新しい保健システム構築のための実証的な疾病負荷研究, G6997658380, G8278189522
OpenAlex ID: W7117678068